• Tue news: Where do Harris and Trump stand on health policy? Medtronic renal denervation coverage. Canada less likely to have drug shortages? Wall Street wants CVS execution plan. Nektar manufacturing facility sale. See more on our front page

Immunology











I don't think so. I just heard that management wants to expand the franchise/therapy area. I did hear that early clinical research in Kenilworth is a target for significant cuts but, then again, who really knows anymore.

There will be big changes in Immunology. Each franchise will be operating from one site, so Boston and Kenilworth will probably merge... but on which site? Likewise with Neuroscience - West Point or Kenilworth?